Skip to main content
. 2020 Feb 9;60(3):564–575. doi: 10.1111/head.13754

Figure 3.

Figure 3

Change in mean (95% CI) (A) headache days and (B) severe headache days per 28‐day period vs baseline. OnabotA = onabotulinumtoxinA. *P = .037 for onabotulinumtoxinA 74 U vs placebo.